本研究针对子痫前期（PE）预测中血管生成因子sFlt-1/PlGF比值假阳性率高的问题，通过前瞻性多中心研究验证NT-proBNP的增量价值 ...

In people with no history of CV disease, N-terminal pro-brain natriuretic peptide (NT-proBNP) levels can predict a higher risk of developing CV disease across various blood pressure and pulse pressure ...

Pharmacokinetics (PK) and pharmacodynamics (PD) in First-MIND: A phase Ib, open-label, randomized study of tafasitamab (tafa) ± lenalidomide (LEN) in addition to R-CHOP in patients (pts) with newly ...

June 18, 2009 (St Paul, Minnesota) — Plasma levels of N-terminal fragment of B-type natriuretic peptide (NT-proBNP) were significantly increased in association with asymptomatic LV systolic or ...

Phase I study of sunitinib (S) in combination with metronomic dosing of cyclophosphamide and methotrexate (CM) in patients with metastatic breast cancer (MBC) No significant financial relationships to ...

Measuring N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels preoperatively among patients scheduled to undergo inpatient noncardiac surgery can strongly predict the risk of major cardiac ...

NT-proBNP is a cornerstone biomarker in the diagnosis and management of heart failure. Despite its widespread use, important biological and analytical challenges remain. One of the most significant is ...

NT-proBNP testing should become compulsory for referring patients to specialist heart failure services to improve diagnosis of the condition in primary care, an expert report has said. The Alliance ...

A discussion on the link between LVEF, nT-proBNP, and cardiac remodeling in predicting disease progression. Scott D. Solomon, MD: It’s important to remember that ejection fraction and natriuretic ...